CDT1 and hepatocellular carcinoma: Research has shown that reducing CDT1 expression can significantly inhibit the malignant behavior of HCC cells (Yao et al., 2023), which indicates that USP37 may influence tumor progression by modulating the activity of CDT1 and other interacting proteins, requiring further investigation.